Showing results (141-150 of 162) with videos related to
Sort By:
Pageof 17
The American Journal of Medicine|May 1, 1986
Serologic changes during induction of lupus-like disease by procainamideR L Rubin, S R Nusinow, A D Johnson, et al.Circulation|August 1, 1975
Functional evaluation of the porcine heterograft in the mitral positionA D Johnson, P O Daily, K L Peterson, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 1, 1990
Accelerated fractionation radiotherapy for advanced head and neck cancerD S Lamb, N A Spry, A J Gray, et al.The New Zealand Medical Journal|November 14, 1990
Results of treatment of cancer of the cervix in Wellington 1980-4D S Lamb, G R Duncan, L A Symons, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1995
IgG but not other classes of anti-[(H2A-H2B)-DNA] is an early sign of procainamide-induced lupusR L Rubin, R W Burlingame, J E Arnott, et al.Radiology|July 1, 1977
Sodium nitroprusside in the treatment of ergotismC W O'Dell, G B Davis, A D Johnson, et al.AJNR. American Journal of Neuroradiology|October 24, 2015
Preclinical Testing of a Novel Thin Film Nitinol Flow-Diversion Stent in a Rabbit Elastase Aneurysm ModelY Ding, D Dai, D F Kallmes, et al.Cell|April 29, 1999
Net1, a Sir2-associated nucleolar protein required for rDNA silencing and nucleolar integrityA F Straight, W Shou, G J Dowd, et al.Clinical Pharmacology and Therapeutics|February 4, 2011
Pharmacogenomics of the RNA world: structural RNA polymorphisms in drug therapyW Sadee, D Wang, A C Papp, et al.Circulation Research|February 1, 1996
Myocyte enhancer binding factor-2 expression and activity in vascular smooth muscle cells. Association with the activated phenotypeA B Firulli, J M Miano, W Bi, et al.Pageof 17